
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
Product Quality Guarantee
HPLC TEST FEE
$100
PLUS Total amount of the Order + Shipping Fee
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
2X Blend – CJC‑1295 No DAC (5 mg) / Ipamorelin (5 mg)
What is 2X Blend CJC‑1295 No DAC / Ipamorelin?
This 2X blend offers two complementary peptides—CJC‑1295 No DAC (modified GHRH) and Ipamorelin (GHSR agonist)—designed for combined preclinical research on endogenous growth hormone regulation.
CJC‑1295 No DAC is a modified Growth Hormone–Releasing Hormone fragment (1–29) engineered to stimulate pulse-like GH secretion with a short half-life (~30 minutes), ideal for studies involving natural temporal activation of the GH axis [1][2].
Ipamorelin is a pentapeptide ghrelin receptor agonist (sequence Aib–His–D‑2‑Nal–D‑Phe–Lys–NH₂) that selectively prompts GH release without affecting cortisol or prolactin in research models [3][4].
This dual-formulation supports synergistic GH-axis investigations: CJC‑1295 No DAC initiates hypothalamic GHRH receptor activation, while Ipamorelin enhances GH secretion via ghrelin receptor pathways—offering a near-physiological mimicry of GH pulsation in experimental frameworks.
Infographic Placeholder: “2X Blend Overview – GH-axis Synergy”
Caption suggestion: “Dual GH-axis modulation: CJC‑1295 No DAC triggers GHRH receptor; Ipamorelin activates GHSR; combined for enhanced pulsatile GH release.”
Citations
-
Peptides.org monograph: CJC‑1295 No DAC is a short-acting GHRH(1–29) analogue (half-life ~30 min), distinct from DAC variant.
2X Blend Overview – GH-axis Synergy -
Peptides.org: “CJC‑1295 No DAC: Modified GRF(1–29) mimics endogenous GHRH pulse, ideal for acute GH-axis studies.”
2X Blend Overview – GH-axis Synergy -
PubChem Compound Summary for Ipamorelin (CID 9831659): sequence Aib–His–D‑2‑Nal–D‑Phe–Lys–NH₂; formula C₃₈H₄₉N₉O₅; MW 711.9 Da.
2X Blend Overview – GH-axis Synergy -
Peptides.guide entry: Ipamorelin is a selective GHSR agonist promoting GH release without cortisol/prolactin release, used in muscle growth and body composition research.
2X Blend Overview – GH-axis Synergy
- Choosing a selection results in a full page refresh.
- Opens in a new window.